SP
BravenNow
🏒
🏒 Company

Cellectis

French biopharmaceutical company

πŸ“Š Rating

1 news mentions Β· πŸ‘ 0 likes Β· πŸ‘Ž 0 dislikes

πŸ“Œ Topics

  • Biotechnology (1)
  • Financial Markets (1)
  • Healthcare Innovation (1)

🏷️ Keywords

Jefferies (1) Β· Cellectis (1) Β· Buy rating (1) Β· Stock coverage (1) Β· Gene editing (1) Β· CAR-T therapy (1) Β· Biotechnology investment (1) Β· Market analysis (1)

πŸ“– Key Information

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

πŸ“° Related News (1)

πŸ”— Entity Intersection Graph

Jefferies(1)Gene editing(1)Cellectis

People and organizations frequently mentioned alongside Cellectis:

πŸ”— External Links